Be a protector: Join the thousands of faculty, staff who have been vaccinated against COVID-19

April 16, 2021  //  FOUND IN: Our Employees,

Earlier this week, Michigan Medicine surpassed 100,000 doses of the COVID-19 vaccine administered to faculty, staff, patients and community members. Thank you to all who have chosen to take an important preventative measure in the fight to end the pandemic.

If you have not yet received a vaccine, or are hesitant to do so, here are some important things to keep in mind.

Play your part

One hundred thousand thank yous for your part in helping Michigan Medicine reach 100,000 COVID-19 vaccinations!

By receiving a vaccine, you greatly reduce your risk of developing COVID-19 infection. If you do develop COVID-19 infection despite vaccination, you are much less likely to have severe disease or require hospitalization.  

The numbers bear that out: 334 out of 2.3 million fully-vaccinated people in Michigan were reported to have contracted COVID-19 infection — that is 0.014%.

According to the Michigan Department of Health and Human Services: “The number of potential cases identified to date is not in excess of what might be expected with vaccines with 95% efficacy. Studies indicate that even if vaccinated people do become ill, they are far less likely to experience severe illness requiring hospitalization or resulting in death.”

At Michigan Medicine, only two patients required hospitalization for COVID-19 infection in the past month who were fully vaccinated.

On top of a higher chance that you will remain healthy, this will also make it less likely that you will pass the virus on to those who are most vulnerable — including patients, colleagues and family members.

“As health care providers, we have a greater responsibility for protecting those who have entrusted us with their care, as well as keeping our patients and families safe,” said Marschall Runge, M.D., Ph.D. “While I understand that some may be hesitant to get the vaccine, I encourage you to trust your colleagues who have studied the data and acknowledged the safety and effectiveness of ongoing vaccination efforts.”

Safety is a priority

Before receiving approval for emergency use, all three vaccine manufacturers provided evidence that their vaccines were safe and effective.

Additionally, a team of experts from the FDA and the CDC’s Advisory Committee on Immunization Practices reviewed all available data on the safety and efficacy of the vaccines before recommending them for use.

Further evidence is being gathered as vaccinations ramp up, with adverse effects being reported to the CDC and FDA.

It was through these monitoring efforts that a pause was recently recommended by the CDC and FDA on giving out the Johnson & Johnson/Janssen COVID-19 vaccine.

It comes after six women who received the vaccine experienced blood clots within two weeks after vaccination — and after more than 6.8 million people in the U.S. received the one-dose vaccine.

“The risk of blood clots in patients with COVID-19 is far higher than the very small risk of a blood clot following a COVID-19 vaccine,” said Geoffrey Barnes, M.D., M.Sc., a cardiologist and vascular medicine specialist at the Frankel Cardiovascular Center. “Overall, the benefits of COVID-19 vaccination greatly outweigh the very small risks.”

And, as Barnes said, the decision to pause was made out of an abundance of caution and is actually a sign that the well-being of patients remains at the core of the vaccination process, which includes monitoring for any adverse side effects not previously reported from clinical trials.

Share your story

Headlines wants to know why you chose to receive the COVID-19 vaccine! Did you get it to help put an end to the pandemic and get life back to normal? Or was it to protect your parents or grandparents who are at high-risk of complications from COVID-19?

No matter your reason, email it to headlines@med.umich.edu along with a photo that represents why you took your shot (please do not show your vaccination card). You could be featured in an upcoming Headlines story or on digital signs across the organization!

Want to get the vaccine?

If you previously completed the Blue Queue questionnaire and indicated that you did not want to receive the vaccine but have since changed your mind, please fill out the questionnaire again and change your status. Any previous entries will be deleted and you will be eligible to receive an invitation to schedule your vaccine when the next wave of invitations is distributed after completing the questionnaire again.

If you have any questions or problems with the questionnaire, you can email bluequeue@med.umich.edu.

And for a full rundown about how to register for the vaccine, click on these vaccination FAQs.

RELATED STORIES